Goldman Sachs Group Inc Biogen Inc. Call Options Transaction History

Goldman Sachs Group Inc

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 May 14, 2024	BUY	$275.25 - $318.06 $2.01 Million - $2.32 Million	7,300 Added 155.32%	12,000 $3.42 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $2.01 Million - $2.32 Million	7,300 Added 155.32%	12,000 $3.42 Million
Q1 2023 May 14, 2024	SELL	$256.56 - $292.34 $9.47 Million - $10.8 Million	-36,900 Reduced 88.7%	4,700 $1.31 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $9.47 Million - $10.8 Million	-36,900 Reduced 88.7%	4,700 $1.31 Million
Q4 2022 May 14, 2024	SELL	$252.44 - $306.72 $2.52 Million - $3.07 Million	-10,000 Reduced 19.38%	41,600 $11.5 Million

Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $2.52 Million - $3.07 Million	-10,000 Reduced 19.38%	41,600 $11.5 Million
Q3 2022 May 14, 2024	BUY	$194.69 - $268.46 $9.33 Million - $12.9 Million	47,900 Added 1294.59%	51,600 $13.8 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $9.33 Million - $12.9 Million	47,900 Added 1294.59%	51,600 $13.8 Million
Q2 2022 May 14, 2024	BUY	$187.54 - $223.02 $693,898 - $825,174	3,700 New	3,700 $755,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $7.03 Million - $8.86 Million	-36,300 Reduced 90.75%	3,700 $779,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $3.36 Million - $4.32 Million	-15,000 Reduced 27.27%	40,000 $9.6 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $15.6 Million - $20.3 Million	55,000 New	55,000 $15.6 Million

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.